Clinical Trial: Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722650) titled 'Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease' on July 19.

Brief Summary: The goal of this clinical trial is to learn whether a twice-daily dosing schedule of Systane Complete eye drops works as well as a four-times-daily dosing schedule of Thealoz Duo eye drops to treat dry eye disease in adults. The main questions it aims to answer are:

* Does twice-daily Systane Complete provide similar improvement in dry eye symptoms, measured by the Ocular Surface Disease Index (OSDI), compared with four-times-daily Thealoz Duo after 30 days of treatment?

* How do the treatments affect tear film stabilit...